Inventor · disambiguated record
Young Chan Chae
Also filed as: CHAE YOUNG C · CHAE YOUNG CHAN
6 granted patents·7 pending applications·16 citations·filing 2003–2020
77Inventor score
Top patents by PatentIndex Score
13 records- 0182US9309515B2Aptamer which selectively binds to ERBB2 receptor and uses thereofLEE JUNG HWAN·Filed 2011·Granted Apr 12, 2016·6 cites·14 claims
- 0278US8785132B2Aptamer sandwich assaysCHAE YOUNG-CHAN·Filed 2011·Granted Jul 22, 2014·6 cites·17 claims
- 0378US8569252B2Nucleolin specific aptamer and use thereofLEE JUNG-HWAN·Filed 2010·Granted Oct 29, 2013·2 cites·8 claims
- 0476US9650638B2Aptamer for periostin and anti-cancer composition including sameUNIST ACADEMY-INDUSTRY RES CORP·Filed 2012·Granted May 16, 2017·2 cites·12 claims
- 0563US2021069218A1Methods of controlling tumor bioenergetics networksWISTAR INST·Filed 2020·Application pending·0 cites
- 0662US9018185B2Method of diagnosing cancer using a nucleolin specific aptamerPOSTECH ACAD IND FOUND·Filed 2013·Granted Apr 28, 2015·0 cites·7 claims
- 0761US9018186B2Method of treating hyperproliferation of cells using a nucleolin specific aptamerPOSTECH ACAD IND FOUND·Filed 2013·Granted Apr 28, 2015·0 cites·8 claims
- 0854US2016015725A1Methods of controlling tumor bioenergetics networksWISTAR INST·Filed 2013·Application pending·0 cites
- 0952US2014271667A1Methods and Compositions for Neoadjuvant TherapyWISTAR INST·Filed 2014·Application pending·0 cites
- 1052US2006172363A1Peptide complexes containing phospholipase dPOSTECH FOUNDATION·Filed 2003·Application pending·0 cites
- 1151US2022348620A1Engineered Peptide and Peptide Mimetic Compositions and MethodsWISTAR INST·Filed 2020·Application pending·0 cites
- 1244US2009312250A1Epidermal growth factor increasing insulin secretion and lowering blood glucosePOSTECH ACAD IND FOUND·Filed 2007·Application pending·0 cites
- 1343US2015359911A1Aptamer Specific to Integrin alpha-v-beta-3 and Use ThereofPOSTECH ACAD IND FOUND·Filed 2013·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →